MONTRESSA PHILLIPS: Open Payments
NPI 1881350684 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 16 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $503 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $269 |
| Novo Nordisk Inc | 2 | $30 |
| SHIELD THERAPEUTICS INC | 1 | $23 |
| PFIZER INC. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Amgen Inc. | 1 | $16 |
Products named: BREZTRI, FARXIGA, AIRSUPRA, Wegovy, ACCRUFER, PREVNAR 20, XIFAXAN, TRELEGY ELLIPTA.
Industry payments across NC — which companies pay providers there.
